EP Patent

EP2482840A4 — Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome

Assigned to ROSE PHARMA AS · Expires 2013-06-26 · 13y expired

What this patent protects

Patent listed against Remodulin.

Drugs covered by this patent

Patent Metadata

Patent number
EP2482840A4
Jurisdiction
EP
Classification
—
Expires
2013-06-26
Drug substance claim
No
Drug product claim
No
Assignee
ROSE PHARMA AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.